HCPCS Level II code A4290 designates a sacral nerve stimulation test lead, billed per individual lead. This code captures a discrete durable medical equipment component used during sacral neuromodulation testing for urinary and pelvic floor dysfunctions. Nationally, accurate use of A4290 matters for consistent billing of neuromodulation testing supplies and for aligning facility and DME charges with payer policies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for sacral neuromodulation test leads, common billing and service line placement, and payer coverage considerations. The publication summarizes available benchmarks for utilization and reimbursement where provided, highlights relevant policy and coding guidance updates, and clarifies typical site-of-service scenarios for claims processing.

The content is intended for billing managers, compliance officers, and clinicians involved in urology, pelvic floor, and pain management services who need a national perspective on coding, coverage, and administrative considerations for sacral nerve stimulation test leads.